As part of ongoing efforts to modernize its clinical trials framework, Health Canada is planning to introduce measures to support the conduct of decentralized studies. Among these are plans to adopt a formal definition of what constitutes a clinical trial site.
The term is currently not defined in Canadian regulations and has resulted in a “lot of questions regarding this topic coming to our offices,” said Alicja Kasina, a senior regulatory